Socioeconomic and global burden of COVID-19

Abstract

Relevance. Assessment of the burden of disease provides information on the economic consequences of the disease, allows you to assess the social significance, identify areas that require additional clinical and economic research, changes in methodological approaches to the organization of measures for the prevention, early detection and treatment of diseases.The aim. Assessment of the socioeconomic and global burden of COVID-19 in the Russian Federation (RF).Materials and methods. Identification and assessment of direct medical, direct non-medical, and indirect costs associated with the development of the coronavirus epidemic. When calculating the socioeconomic burden, the variant of calculations was chosen taking into account the prevalence of the disease. The sources of data on the epidemiology of the disease were data from the Ministry of Health and data from the Government of the RF.Results. The socioeconomic burden of COVID-19 in 2020 in the RF amounted to about 5.4 trillion rubles (5 % of nominal GDP in 2020) and was largely due to indirect costs due to GDP losses due to a 1.5-month period of self-isolation. The estimated global burden of disease is more than 4 million YLLs globally, of which in the RF 2,486.30 among men and 1,378.22 YLL among women.Conclusion. The epidemic of the new coronavirus infection has led to colossal economic losses in Russian society. The data presented underscore not only the clinical, but also the economic importance of investing in the development of strategies for the treatment and prevention of new coronavirus infection.

A diagnostic and economic evaluation of the complex artificial intelligence algorithm aimed to detect 10 pathologies on the chest CT images

“…An analysis of the socioeconomic burden of the COVID-19 pandemic can serve as an example of the significant social and economic consequences of a mass disease for the Russian healthcare system and society as a whole, which focuses attention not only on the clinical but also on the economic importance of investing in the development of strategies to combat diseases [43]. According to experts, the socioeconomic burden of COVID-19 in the Russian Federation in 2020 amounted to about 5.4 trillion rubles (5% of the nominal GDP in 2020), which corresponds to 2,486 YLL (years of life lost; years of life lost due to premature mortality of the population) among men and 1,378 YLL among women [43]. The economic burden of non-communicable diseases in the Russian Federation for the same year amounted to 4 trillion rubles.…”

Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines

“…В большей степени оно было обусловлено косвенными расходами в связи с потерями валового внутреннего продукта вследствие 1,5-мес. периода самоизоляции [1739]. Согласно данным центров по контролю и профилактике заболеваний США в стране гриппом ежегодно болеют миллионы людей, сотни тысяч госпитализируются, а десятки тысяч умирают от гриппа и связанных с ним осложнений.…”